297 related articles for article (PubMed ID: 10510897)
1. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
[TBL] [Abstract][Full Text] [Related]
3. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
Masunaga S; Ono K; Akaboshi M; Takagaki M; Kinashi Y; Suzuki M; Abe M
Radiat Med; 1997; 15(1):37-43. PubMed ID: 9134583
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
5. Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cells.
Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
Radiat Med; 2003; 21(3):120-7. PubMed ID: 12868860
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
Masunaga S; Nagasawa H; Uto Y; Hori H; Suzuki M; Nagata K; Kinashi Y; Ono K
Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
[TBL] [Abstract][Full Text] [Related]
7. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
Masunaga S; Nagasawa H; Uto Y; Hori H; Ohnishi K; Takahashi A; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
Oncol Rep; 2005 Aug; 14(2):393-400. PubMed ID: 16012721
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
[TBL] [Abstract][Full Text] [Related]
9. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.
Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
Br J Radiol; 2000 Sep; 73(873):978-86. PubMed ID: 11064652
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
[TBL] [Abstract][Full Text] [Related]
11. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
12. Dependency of repair of radiation-induced damage on p53 status and efficient inhibition of the repair with wortmannin treatment in vivo, with reference to the effect on intratumor quiescent cell population.
Masunaga S; Takahashi A; Ohnishi K; Nagata K; Suzuki M; Kashino G; Kinashi Y; Ohnishi T; Ono K
Oncol Rep; 2007 Dec; 18(6):1589-96. PubMed ID: 17982649
[TBL] [Abstract][Full Text] [Related]
13. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
J Cancer Res Clin Oncol; 1999 Nov; 125(11):609-14. PubMed ID: 10541967
[TBL] [Abstract][Full Text] [Related]
14. Effects of mild temperature hyperthermia and p53 status on the size of hypoxic fractions in solid tumors, with reference to the effect in intratumor quiescent cell populations.
Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Nagata K; Suzuki M; Kinashi Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):570-7. PubMed ID: 15380594
[TBL] [Abstract][Full Text] [Related]
15. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
16. The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo.
Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Ono K
Acta Oncol; 2008; 47(6):1087-93. PubMed ID: 18607878
[TBL] [Abstract][Full Text] [Related]
17. A method for the selective measurement of the radiosensitivity of quiescent cells in solid tumors--combination of immunofluorescence staining to BrdU and micronucleus assay.
Masunaga S; Ono K; Abe M
Radiat Res; 1991 Mar; 125(3):243-7. PubMed ID: 1705716
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo.
Masunaga S; Tano K; Watanabe M; Kashino G; Suzuki M; Kinashi Y; Ono K; Nakamura J
Br J Radiol; 2009 May; 82(977):392-400. PubMed ID: 19153181
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Suzuki M; Kinashi Y; Takagaki M; Hori H; Kasai S; Nagasawa H; Uto Y
Jpn J Cancer Res; 2000 May; 91(5):566-72. PubMed ID: 10835503
[TBL] [Abstract][Full Text] [Related]
20. Effects of bioreductive agents, tirapazamine and mitomycin C, on quiescent cell populations in solid tumors, evaluated by micronucleus assay.
Masunaga S; Ono K; Hori H; Shibata T; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
Jpn J Cancer Res; 1997 Sep; 88(9):907-14. PubMed ID: 9369940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]